Literature DB >> 5428623

Abnormal fibrin ultrastructure, polymerization, and clot retraction in multiple myeloma.

H Lackner, V Hunt, M B Zucker, J Pearson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5428623     DOI： 10.1111/j.1365-2141.1970.tb01587.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  Antibody-mediated tissue damage. Hyperviscosity and other complications of paraproteinaemia.

Authors:  F E Preston
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  Acute renal failure in myelomatosis from intravascular coagulation.

Authors:  F E Preston; A M Ward
Journal:  Br Med J       Date:  1972-03-04

3.  Quantitative N-terminal analysis of fibrinogen-fibrin-related antigen [FR antigen] from human plasma.

Authors:  J U Harris; A J Johnson; C Merskey; M T Wang; D Robinson
Journal:  Biochem J       Date:  1979-12-01       Impact factor: 3.857

4.  Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder.

Authors:  M S Khoory; M E Nesheim; E J Bowie; K G Mann
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

5.  A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder.

Authors:  G DiMinno; F Coraggio; A M Cerbone; A M Capitanio; C Manzo; M Spina; P Scarpato; G M Dattoli; P L Mattioli; M Mancini
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

6.  The kidney and intravascular coagulation in myelomatosis.

Authors:  A M Ward; F E Preston
Journal:  Br Med J       Date:  1974-06-08

7.  Pulmonary embolism as the first manifestation of multiple myeloma.

Authors:  N Vallianou; V Lazarou; J Tzangarakis; R Barounis; E Sioula
Journal:  Case Rep Med       Date:  2013-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.